DotLab Funding & Investors
DotLab™ is a women’s healthcare technology company developing DotEndo™, a breakthrough, non-invasive, blood test to aid in the diagnosis of active endometriosis.
dotlab.comTotal Amount Raised: $12,650,000
DotLab Funding Rounds
Series A
$10,000,000
Series A Investors
CooperSurgicalWilson Sonsini Goodrich & RosatiLuxor Capital GroupTiger Global ManagementSeed
$2,650,000
Funding info provided by Diffbot.